Rocket


News + Filings
Key Docs
Ownership





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Haleon plc Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 6-K Quarterly results
10/11/2023 6-K Quarterly results
10/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "HOLDING(S) IN COMPANY"
10/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
09/28/2023 6-K Quarterly results
08/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
08/02/2023 6-K Quarterly results
08/02/2023 6-K Quarterly results
07/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
06/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
05/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "HOLDING(S) IN COMPANY"
05/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "HOLDING(S) IN COMPANY"
05/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "EMTN PROGRAMME PUBLICATION OF BASE PROSPECTUS"
05/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
05/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
05/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "2023 Q1 TRADING STATEMENT"
05/03/2023 6-K Quarterly results
04/20/2023 6-K Quarterly results
04/20/2023 6-K Quarterly results
04/20/2023 6-K Quarterly results
04/14/2023 6-K Quarterly results
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
03/20/2023 6-K Quarterly results
03/20/2023 6-K Quarterly results
03/20/2023 6-K Quarterly results
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
03/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "ENVIRONMENTAL & SOCIAL SUSTAINABILITY COMMITTEE"
03/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "DIRECTOR/PDMR SHAREHOLDING"
03/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "HALEON FULL YEAR RESULTS 2022"
03/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"2022 Full Year Results Announcement"
02/13/2023 6-K Quarterly results
02/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "OUTCOME OF AUDIT TENDER"
02/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Haleon plc: Board changes In accordance with 9.6.11R of the UK Listing Rules, Haleon plc announced on 31 January 2023 that John Young, Non-Executive Director and representative of Pfizer Inc. , will be stepping down from the Board of the Company with effect from 28 February 2023. John will be succeeded as Non-Executive Director and representative of Pfizer by David Denton with effect from 1 March 2023. Dave is the Chief Financial Officer and Executive Vice President for Pfizer and brings more than 20 years of healthcare experience. Sir Dave Lewis, Chair of Haleon plc said: “On behalf of the Board, I would like to thank John for his significant role in the joint venture between Pfizer and GSK plc in 2019 which created the premier global consumer healthcare business that is Haleon today. Jo..."
01/31/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "BOARD CHANGES"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy